Difference between revisions of "WSI23-224-Case-1"

From MGH Learn Pathology
Line 21: Line 21:
 
}}
 
}}
 
{{Media
 
{{Media
|identifier=59f378a2-6b41-40ba-87ac-b38ff46b50fd
+
|identifier=bf8893f6-60c0-4d87-828c-67679f0c703c
 
|operator=Abw33
 
|operator=Abw33
 
|status=completed
 
|status=completed
Line 29: Line 29:
 
}}
 
}}
 
{{Media
 
{{Media
|identifier=a9eaea72-f75c-45a9-b42d-a74365181bc7
+
|identifier=96472a78-815d-405c-82d7-4e42adb860d9
 
|operator=Abw33
 
|operator=Abw33
 
|status=completed
 
|status=completed
Line 37: Line 37:
 
}}
 
}}
 
{{Media
 
{{Media
|identifier=3ee731a8-4ada-4966-9965-146871ed11d4
+
|identifier=185d2905-d0ea-4918-a656-78362ebe7c39
 
|operator=Abw33
 
|operator=Abw33
 
|status=completed
 
|status=completed

Revision as of 18:28, January 9, 2024

WSI23-224-Case-1
16F with multisystem organ dysfunction in the setting of SLE and macrophage activation syndrome s/p multiple abdominal surgeries at OSH and left arm amputation/shoulder disarticulation secondary to ischemic injury.
Extensive necrosis and angioinvasive fungal infection, morphologically consistent with Mucormycosis, with diffuse tissue infiltration without significant inflammatory reaction.
January 9, 2024 12:00:00 PM